Loading
No insider purchase over the last 90 days. The latest, by KATZAROFF JAMES C, was filed 29 Aug 2023.
VirExit Technologies, Inc.: what insiders have been doing
Only a handful of insider records exist for VirExit Technologies, Inc., the last one from 29 August 2023, too few to describe a trend. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€9,237
1 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +15.6%Entry US$0.00 · Close at T+365 US$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended August 2018 · cache
US$0.00
Analyst consensus
Income statement
Net income-US$1.6M0.0% margin
Valuation
Beta-0.24
Profitability & ownership
ROA-1908.6%
% institutions0.0%
Last declaration on 29 August 2023
Declarations1 total
11,111,111 shares@ US$0.0009100.0% of flowCommon stockSEC:0001161697-23-000467:0
Canonical exit: 26 Nov 2023 (T+90)
1 of 1 declaration
About VirExit Technologies, Inc.
VirExit Technologies, Inc. is a company listed on the XNAS market, specializing in the development of technological solutions for the healthcare sector. It focuses on innovation in treatments and services related to mental health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
